Since IBD is associated with many genetic variants that affect bacterial clearance, such as NOD2, and autophagy, such as ATG16L1 (15), we assumed that increased bacterial clearance after α-TREM-1 treatment resulted from increased autophagy. This evidence concerns the gene ATG16L1 and inflammatory bowel disease.